|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
1.000
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
1.000
|
|
|
regulation of activation of jak2 kinase activity
|
GO:0010534 |
1 |
1.000
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
1.000
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
1.000
|
|
|
lactation
|
GO:0007595 |
25 |
1.000
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
1.000
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
1.000
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
1.000
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
1.000
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
1.000
|
|
|
negative regulation of cellular response to insulin stimulus
|
GO:1900077 |
16 |
1.000
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
1.000
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
1.000
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
1.000
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
1.000
|
|
|
negative regulation of t helper 2 cell differentiation
|
GO:0045629 |
4 |
1.000
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
1.000
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
1.000
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
1.000
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
1.000
|
|
|
response to peptide
|
GO:1901652 |
136 |
1.000
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
1.000
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
1.000
|
|
|
creatinine metabolic process
|
GO:0046449 |
3 |
1.000
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
1.000
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
1.000
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
1.000
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
1.000
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.999
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.999
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.999
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.999
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.999
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.999
|
|
|
layer formation in cerebral cortex
|
GO:0021819 |
13 |
0.999
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.999
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.999
|
|
|
regulation of activation of janus kinase activity
|
GO:0010533 |
1 |
0.999
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.999
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.999
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.999
|
|
|
tyrosine phosphorylation of stat1 protein
|
GO:0042508 |
3 |
0.999
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.999
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.998
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.998
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
22 |
0.998
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.998
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.998
|
|
|
tyrosine phosphorylation of stat protein
|
GO:0007260 |
23 |
0.998
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.998
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.998
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.998
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.998
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.998
|
|
|
negative regulation of insulin receptor signaling pathway
|
GO:0046627 |
14 |
0.998
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.997
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.997
|
|
|
tyrosine phosphorylation of stat3 protein
|
GO:0042503 |
12 |
0.997
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.997
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.997
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.997
|
Mouse |
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.997
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
17 |
0.997
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.997
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.997
|
Mouse |
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.997
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.996
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.996
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.996
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.995
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.995
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.995
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.995
|
|
|
glucose import
|
GO:0046323 |
32 |
0.995
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.995
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.995
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.995
|
|
|
radial glia guided migration of purkinje cell
|
GO:0021942 |
6 |
0.994
|
|
|
taurine metabolic process
|
GO:0019530 |
4 |
0.994
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.994
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.993
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.993
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.993
|
|
|
cellular response to growth hormone stimulus
|
GO:0071378 |
7 |
0.993
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.993
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.993
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.992
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.992
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.992
|
|
|
creatine metabolic process
|
GO:0006600 |
4 |
0.992
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.992
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.992
|
|
|
negative regulation of tyrosine phosphorylation of stat3 protein
|
GO:0042518 |
1 |
0.992
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.992
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.991
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.991
|
|
|
regulation of glutamine family amino acid metabolic process
|
GO:0000820 |
1 |
0.991
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.990
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.990
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.990
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.990
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.990
|
|
|
activation of jak2 kinase activity
|
GO:0042977 |
2 |
0.990
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.989
|
|
|
negative regulation of tyrosine phosphorylation of stat protein
|
GO:0042532 |
3 |
0.989
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.989
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.989
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.989
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.989
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.989
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.989
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.989
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.989
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.989
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.988
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.988
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.988
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.988
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.988
|
|
|
prolactin signaling pathway
|
GO:0038161 |
5 |
0.987
|
|
|
mammary gland alveolus development
|
GO:0060749 |
22 |
0.987
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.987
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.986
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.986
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.986
|
|
|
regulation of natural killer cell differentiation
|
GO:0032823 |
11 |
0.986
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.985
|
|
|
regulation of serotonin uptake
|
GO:0051611 |
2 |
0.985
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.984
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.984
|
|
|
neuron death
|
GO:0070997 |
154 |
0.984
|
Mouse |
|
regulation of cell migration
|
GO:0030334 |
219 |
0.984
|
|
|
positive regulation of adrenergic receptor signaling pathway
|
GO:0071879 |
3 |
0.984
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.984
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.983
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.983
|
|
|
regulation of the force of heart contraction by chemical signal
|
GO:0003057 |
5 |
0.983
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.983
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.983
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.983
|
|
|
adrenal gland development
|
GO:0030325 |
18 |
0.982
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.982
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.982
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.981
|
Mouse |
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.981
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.981
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.981
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.981
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.980
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.980
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.979
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.979
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.979
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.979
|
|
|
cerebral cortex radial glia guided migration
|
GO:0021801 |
17 |
0.979
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.979
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.979
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.979
|
|
|
positive regulation of dephosphorylation
|
GO:0035306 |
6 |
0.978
|
|
|
negative regulation of interferon gamma mediated signaling pathway
|
GO:0060336 |
1 |
0.978
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.977
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.977
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.977
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.976
|
|
|
regulation of carbohydrate catabolic process
|
GO:0043470 |
12 |
0.975
|
|
|
regulation of tyrosine phosphorylation of stat protein
|
GO:0042509 |
20 |
0.975
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.975
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.975
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.975
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.975
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.974
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.974
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.974
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.974
|
|
|
negative regulation of feeding behavior
|
GO:2000252 |
1 |
0.974
|
|
|
positive regulation of lipid kinase activity
|
GO:0090218 |
11 |
0.973
|
|
|
g protein coupled receptor signaling pathway involved in heart process
|
GO:0086103 |
4 |
0.973
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.973
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.973
|
|
|
cellular response to increased oxygen levels
|
GO:0036295 |
1 |
0.973
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.972
|
|
|
regulation of mammary gland involution
|
GO:1903519 |
4 |
0.972
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.972
|
|
|
allantoin metabolic process
|
GO:0000255 |
3 |
0.972
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.972
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.972
|
|
|
regulation of nitric oxide synthase activity
|
GO:0050999 |
6 |
0.972
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.971
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.971
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.971
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.971
|
|
|
response to growth hormone
|
GO:0060416 |
7 |
0.970
|
|
|
protein nitrosylation
|
GO:0017014 |
4 |
0.969
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.969
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.969
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.968
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.968
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.968
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.968
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.968
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.967
|
|
|
negative regulation of neurotransmitter transport
|
GO:0051589 |
7 |
0.967
|
|
|
negative regulation of response to food
|
GO:0032096 |
7 |
0.967
|
|
|
isoleucine metabolic process
|
GO:0006549 |
4 |
0.967
|
|
|
pallium development
|
GO:0021543 |
120 |
0.967
|
|
|
negative regulation of neurotrophin trk receptor signaling pathway
|
GO:0051387 |
2 |
0.966
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.966
|
|
|
mammary gland branching involved in pregnancy
|
GO:0060745 |
6 |
0.966
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.966
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.965
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.965
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.964
|
|
|
response to camp
|
GO:0051591 |
14 |
0.964
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.963
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.963
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.963
|
|
|
succinate metabolic process
|
GO:0006105 |
4 |
0.962
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.961
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.958
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.958
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.958
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.957
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.957
|
|
|
regulation of t helper cell differentiation
|
GO:0045622 |
14 |
0.956
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.956
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.955
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.955
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.954
|
|
|
cellular response to bile acid
|
GO:1903413 |
1 |
0.953
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.953
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.953
|
|
|
adrenergic receptor signaling pathway
|
GO:0071875 |
13 |
0.952
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.952
|
|
|
regulation of tyrosine phosphorylation of stat3 protein
|
GO:0042516 |
10 |
0.952
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.952
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.951
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.951
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.951
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.950
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.950
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.950
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.949
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.948
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.948
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.947
|
|
|
response to estradiol
|
GO:0032355 |
12 |
0.947
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.947
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.946
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.946
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.946
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.945
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.944
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.942
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.941
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.941
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.941
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.940
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.940
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.939
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.938
|
|
|
response to food
|
GO:0032094 |
17 |
0.938
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.937
|
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
24 |
0.937
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.937
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.937
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.936
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.936
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.934
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.932
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.932
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.931
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.928
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
25 |
0.928
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.927
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.926
|
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.926
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.926
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.925
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.924
|
|
|
trophectodermal cell proliferation
|
GO:0001834 |
2 |
0.924
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.923
|
|
|
regulation of t helper 1 cell differentiation
|
GO:0045625 |
7 |
0.923
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.923
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.923
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.923
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.922
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.922
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.921
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.920
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.920
|
|
|
camp mediated signaling
|
GO:0019933 |
15 |
0.920
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.920
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.919
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
13 |
0.919
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.918
|
|
|
negative regulation of calcium ion transport
|
GO:0051926 |
9 |
0.916
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.915
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.914
|
|
|
regulation of glucagon secretion
|
GO:0070092 |
2 |
0.914
|
|
|
negative regulation of triglyceride metabolic process
|
GO:0090209 |
4 |
0.913
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.910
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.910
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
18 |
0.910
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.909
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.909
|
|
|
interleukin 18 mediated signaling pathway
|
GO:0035655 |
2 |
0.908
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.908
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.908
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.907
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.906
|
|
|
vasodilation by angiotensin involved in regulation of systemic arterial blood pressure
|
GO:0002033 |
2 |
0.906
|
|
|
response to granulocyte macrophage colony stimulating factor
|
GO:0097012 |
3 |
0.905
|
|
|
regulation of transcription involved in cell fate commitment
|
GO:0060850 |
15 |
0.905
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.904
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.904
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.904
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.904
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.904
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.904
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.903
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.902
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.902
|
|
|
response to dexamethasone
|
GO:0071548 |
8 |
0.902
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.901
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.900
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.898
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.898
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.896
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.896
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.896
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.896
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.895
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.894
|
|
|
ossification
|
GO:0001503 |
216 |
0.894
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.893
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.893
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.892
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.891
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.889
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.889
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.885
|
|
|
regulation of glucocorticoid secretion
|
GO:2000849 |
5 |
0.883
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.883
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.882
|
|
|
steroid hormone mediated signaling pathway
|
GO:0043401 |
6 |
0.880
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.879
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.879
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.879
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.878
|
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
18 |
0.876
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
7 |
0.876
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.876
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.876
|
|
|
positive regulation of cellular response to insulin stimulus
|
GO:1900078 |
9 |
0.875
|
|
|
regulation of steroid hormone biosynthetic process
|
GO:0090030 |
4 |
0.873
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.872
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.872
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.872
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.870
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.869
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.869
|
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.868
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.867
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.867
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.867
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.867
|
|
|
gland development
|
GO:0048732 |
330 |
0.865
|
|
|
cellular response to vitamin
|
GO:0071295 |
2 |
0.865
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.865
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.864
|
|
|
response to interleukin 15
|
GO:0070672 |
3 |
0.863
|
|
|
positive regulation of activated t cell proliferation
|
GO:0042104 |
8 |
0.863
|
|
|
negative regulation of appetite
|
GO:0032099 |
7 |
0.863
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.862
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.861
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.861
|
|
|
protein processing
|
GO:0016485 |
163 |
0.861
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.860
|
|
|
regulation of lipid kinase activity
|
GO:0043550 |
14 |
0.860
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.859
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.859
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.855
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.855
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.855
|
Mouse |
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
18 |
0.854
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.853
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.853
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.853
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.852
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.852
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.852
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.851
|
|
|
cellular lactam metabolic process
|
GO:0072338 |
3 |
0.850
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.850
|
|
|
regulation of fatty acid beta oxidation
|
GO:0031998 |
1 |
0.848
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.848
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.847
|
|
|
regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:1902253 |
13 |
0.847
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.846
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.846
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.845
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.845
|
|
|
ovulation from ovarian follicle
|
GO:0001542 |
9 |
0.844
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.842
|
Mouse |
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.842
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.840
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.840
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.840
|
|
|
branching involved in labyrinthine layer morphogenesis
|
GO:0060670 |
9 |
0.839
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.839
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.838
|
|
|
hindbrain radial glia guided cell migration
|
GO:0021932 |
12 |
0.838
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.836
|
|
|
valine metabolic process
|
GO:0006573 |
4 |
0.836
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.836
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.836
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.836
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.836
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.836
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.835
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.834
|
|
|
regulation of glycolytic process
|
GO:0006110 |
10 |
0.834
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.833
|
|
|
arginine metabolic process
|
GO:0006525 |
2 |
0.832
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.831
|
|
|
negative regulation of release of cytochrome c from mitochondria
|
GO:0090201 |
6 |
0.830
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.830
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.828
|
|
|
positive regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033145 |
4 |
0.827
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.827
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.825
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.825
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.825
|
|
|
tyrosine phosphorylation of stat5 protein
|
GO:0042506 |
9 |
0.824
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.824
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.823
|
|
|
negative regulation of muscle adaptation
|
GO:0014745 |
2 |
0.822
|
|
|
tor signaling
|
GO:0031929 |
21 |
0.822
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.821
|
|
|
positive regulation of epidermal growth factor receptor signaling pathway
|
GO:0045742 |
5 |
0.821
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.819
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.816
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.816
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.815
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.813
|
|
|
negative regulation of serotonin uptake
|
GO:0051612 |
2 |
0.813
|
|
|
positive regulation of brown fat cell differentiation
|
GO:0090336 |
4 |
0.813
|
|
|
cellular response to drug
|
GO:0035690 |
15 |
0.810
|
|
|
regulation of appetite
|
GO:0032098 |
12 |
0.810
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.809
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.809
|
|
|
negative regulation of peptide hormone secretion
|
GO:0090278 |
16 |
0.809
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.809
|
|
|
positive regulation of glycogen metabolic process
|
GO:0070875 |
8 |
0.807
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.805
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.805
|
|
|
regulation of t helper 2 cell differentiation
|
GO:0045628 |
8 |
0.805
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.803
|
|
|
positive regulation of carbohydrate metabolic process
|
GO:0045913 |
30 |
0.803
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.802
|
|
|
response to isoquinoline alkaloid
|
GO:0014072 |
9 |
0.802
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.800
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.799
|
Mouse |
|
pancreas development
|
GO:0031016 |
57 |
0.799
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.798
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.798
|
|
|
bile acid metabolic process
|
GO:0008206 |
17 |
0.797
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.796
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.796
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.796
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.795
|
|
|
glucagon secretion
|
GO:0070091 |
3 |
0.794
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.794
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.793
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.793
|
|
|
negative regulation of cytosolic calcium ion concentration
|
GO:0051481 |
2 |
0.792
|
|
|
glucocorticoid mediated signaling pathway
|
GO:0043402 |
3 |
0.792
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.791
|
|
|
response to morphine
|
GO:0043278 |
9 |
0.790
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.790
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.789
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.788
|
|